6-o-veratroyl catalpol has been researched along with galangin in 2 studies
| Studies (6-o-veratroyl catalpol) | Trials (6-o-veratroyl catalpol) | Recent Studies (post-2010) (6-o-veratroyl catalpol) | Studies (galangin) | Trials (galangin) | Recent Studies (post-2010) (galangin) |
|---|---|---|---|---|---|
| 6 | 0 | 5 | 366 | 0 | 238 |
| Protein | Taxonomy | 6-o-veratroyl catalpol (IC50) | galangin (IC50) |
|---|---|---|---|
| TPA: protein transporter TIM10 | Saccharomyces cerevisiae S288C | 35.5 | |
| TPA: protein transporter TIM23 | Saccharomyces cerevisiae S288C | 8.56 | |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | Oryctolagus cuniculus (rabbit) | 9 | |
| Cytochrome P450 1A1 | Homo sapiens (human) | 0.077 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 0.04 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 0.13 | |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | 3.65 | |
| Xanthine dehydrogenase/oxidase | Homo sapiens (human) | 1.8 | |
| Cytochrome P450 1B1 | Homo sapiens (human) | 0.014 | |
| Aurora kinase B | Homo sapiens (human) | 9.8 | |
| Short transient receptor potential channel 5 | Homo sapiens (human) | 0.45 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chin, YW; Jee, JG; Jeong, YJ; Keum, YS; Kim, Y; Lee, J; Lee, JM; Yu, MS | 1 |
| Ahn, HC; Cho, SC; Choi, BY; Fei, X; Keum, YS; Kim, HJ; Lee, K; Seo, SY | 1 |
2 other study(ies) available for 6-o-veratroyl catalpol and galangin
| Article | Year |
|---|---|
Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13.
Topics: Adenosine Triphosphate; Antiviral Agents; Apigenin; Breast; Cell Line; Cell Proliferation; Colorimetry; DNA; DNA Helicases; Epithelial Cells; Female; Flavonoids; Fluorescence Resonance Energy Transfer; Hepacivirus; Humans; Hydrolysis; Inhibitory Concentration 50; Kinetics; Methyltransferases; RNA Helicases; Severe acute respiratory syndrome-related coronavirus; Species Specificity; Viral Nonstructural Proteins; Viral Proteins | 2012 |
Discovery of α-mangostin as a novel competitive inhibitor against mutant isocitrate dehydrogenase-1.
Topics: Binding, Competitive; Drug Discovery; Humans; Isocitrate Dehydrogenase; MCF-7 Cells; Molecular Structure; Mutation; Recombinant Proteins; Structure-Activity Relationship; Xanthones | 2015 |